During last night’s earnings call, Chromadex CEO Rob Fried discussed the results of recent clinical trials using NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes). Here’s what he said:
Category: Parkinsons
We’ve written a lot about ongoing clinical trials testing NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) for Parkinson’s patients. Fortunately, Chromadex (NR sellers) CEO Rob Fried gave the following update on those trials at an investor conference earlier this week:
While we await data from clinical trials on the efficacy of NAD+ boosters like Nicotinamide Riboside “NR” (FAQs) (Anecdotes) and Nicotinamide Mononucleotide “NMN” (FAQs and Anecdotes), we’re always on the lookout for comments from experts in the field to hear their current thinking. Earlier this week at an investor conference, Chromadex (NR seller) management had the following to say about NR for Parkinson’s patients (transcript and video below):
On July 21st, Science published a paper entitled “What is really known about the effects of nicotinamide riboside supplementation in humans“. Below is the authors’ conclusion followed by reaction from Dr. Charles Brenner (FAQs) who discovered Nicotinamide Riboside “NR” (FAQs) (Anecdotes) as an NAD+ precursor vitamin:
Last week, NAD+ expert Dr. Charles Brenner (FAQs) was a guest on the “Beauty and the BS” podcast with Dr. Peter Grossman. They covered a wide range of topics including NAD+, Nicotinamide Riboside “NR” (FAQs) (Anecdotes), NMN (FAQs, Anecdotes), and anti-aging. Most notably, Dr. Brenner said the following in response to a question about the safety of NR (video excerpt embedded below):
In honor of Parkinson’s Awareness Month, Labiotech has a comprehensive piece examining five recent advancements in Parkinson’s disease research. Here’s an excerpt from the section on NAD+ boosting vitamin Nicotinamide Riboside “NR” (FAQs) (Anecdotes):
Parkinson’s expert Dr. Charalampos (Haris) Tzoulis is actively running clinical trials studying NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) as a possible treatment option for Parkinson’s patients. He’s clearly optimistic. And, as you’ll see below, this is consistent with what we’ve heard from NAD+ experts Dr. Charles Brenner (FAQs) and Dr. David Sinclair in regards to their preferred NAD+ precursors, NR and NMN, respectively:
During the Q&A portion of last week’s presentation, Parkinson’s expert Dr. Charalampos (Haris) Tzoulis was asked if, based on his ongoing clinical trials studying vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes), he had any advice for consumers looking to prevent neurological disorders such as Parkinson’s. Here’s what he said:
Dr. Charalampos (Haris) Tzoulis, a Parkinson’s expert, and Professor of Neurology and Neurodegeneration at the University of Bergen is currently overseeing clinical trials studying NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes) as a possible treatment for Parkinson’s patients. In a recent presentation, Dr. Tzoulis explained why he chose to use NR as opposed to any other NAD+ precursor:
Earlier this week, Ladenburg Thalmann, a US investment firm hosted a Healthcare Symposia. One of its guest speakers was Dr. Charalampos (Haris) Tzoulis, Professor of Neurology and Neurodegeneration at the University of Bergen and Haukeland University Hospital, Bergen Norway. Dr. Tzoulis recently completed a Phase 1 clinical trial testing vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes) in Parkinson’s patients. Here’s how Dr. Tzoulis explained why he initiated the study:
Last week, a Twitter user asked Dr. Charles Brenner for research on the potential neuroprotective benefits of NAD+ vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Consumer Anecdotes). Here’s how Dr. Brenner responded:
During a recent interview at the Longevity Investors Conference, Dr. Charles Brenner was asked whether NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Consumer Anecdotes) should be considered a longevity intervention. Here’s what he said (video and transcript below):
During last night’s earnings conference call, Chromadex management commented on recent clinical studies involving NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) and Parkinson’s. The following are key quotes:
A site called The Science of Parkinson’s (Plain English information about the research being conducted on Parkinson’s) recently published a substantive post examining results from the Parkinson’s / Nicotinamide Riboside “NR” (FAQs) (Reviews) clinical trial out of Norway published in March. While we encourage you to read the post in its entirety, here’s the concluding key quote:
We know there’s significant interest in NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) as a potential treatment for Alzheimer’s Disease (Link). It appears the same can now be said for NR and Parkinson’s. The following are results of a Phase 1 clinical trial published yesterday (Note: A Phase 2 study is already underway):
Harvard’s Dr. Rudy Tanzi is a leading expert studying Alzheimer’s disease. He also happens to be a passionate believer in NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). As a result of his lab work, he’s launching a clinical trial looking at NR in individuals with mild cognitive impairment (MCI) and mild Alzheimer’s dementia (AD) (actual start date March 2, 2022). Here’s why:
We know that world renowned Alzheimer’s expert Dr. Rudy Tanzi believes in B3 vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). He takes NR daily, he’s conducting a clinical trial studying NR as a possible treatment for Alzheimer’s, and he also recently recommended it to Dr. Oz’s mother who’s currently suffering from that very debilitating disease. What about NR as a possible treatment for Parkinson’s? There’s reason to believe NR could help. Here’s the latest on a recent Parkinson’s/NR clinical trial out of Norway:
We know that there’s enormous interest in studying Nicotinamide Riboside “NR” (FAQs) (Reviews) in the science community. A quick look at the 50+ ongoing or completed clinical trials says it all. But who are these scientists? Chromadex CEO Rob Fried talked about some of them at the Oppenheimer Health Care Conference yesterday.
A popular YouTube channel called Bestie (3.4m subs) posted a short but substantive video this week with Nicotinamide Riboside “NR” (FAQs) (Reviews) topping a list of “6 Supplements That’ll Help You Build A Better Brain” (Turmeric, Lion’s Mane Mushrooms, Seafood, Vitamin D3). Transcript and video embedded below.
We know that one of the world’s top Alzheimer’s experts recently initiated clinical trials testing vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) on human patients. But what about Parkinson’s disease? Both Dr David Sinclair and Dr Charles Brenner agree that there’s good reason for clinical trials testing NAD boosters on those suffering from neurodegenerative diseases. So, what’s the latest? Dr. Brenner (NAD expert and discoverer of NR as an NAD precursor vitamin) made the following comment on Twitter earlier this week.
Harvard Alzheimer’s Expert Explains Why “I Religiously Take Tru Niagen” (Nicotinamide Riboside “NR”)
In a mid-November podcast appearance, Harvard neuroscientist and Alzheimer’s expert Dr. Rudy Tanzi made a compelling case for supplementing with Nicotinamide Riboside “NR” (FAQs) (Reviews). This week, he joined host Linda Cooper on “The New 100 Longevity Campaign” and shared even more. The following are key quotes.
Educating the public about NAD is a monumental challenge. And it’s obviously key to those companies selling NAD boosters. But thanks to Dr. Rhonda Patrick of FoundMyFitness the concept of NAD is much more accessible. Here she is on the Joe Rogan Podcast:
Harvard Genetics Professor David Sinclair PhD, author of Lifespan, joined Kahn Academy last week to talk NAD and much more. Sinclair excels at discussing NAD, longevity, and science in easily accessible ways. The following are key quotes from his 40 minute interview with Sal Kahn (video embedded below):
Dr. Charles Brenner (FAQs), who discovered Nicotinamide Riboside “NR” (FAQs) (Reviews) as an NAD boosting vitamin and is actively studying NR’s impact on the treatment of COVID-19 recently joined YOU The Owner’s Manual Podcast (Host Dr. Michael Roizen is Chief Wellness Officer at Cleveland Clinic) to discuss his latest research. Key quotes and podcast embedded below:
Dr. Charles Brenner, who discovered Nicotinamide Riboside “NR” (FAQs) (Reviews) as an NAD boosting vitamin and is actively studying NR’s impact on the treatment of COVID-19 recently joined PRECISIONE: The Healthcast podcast to discuss his latest research. Key quotes and podcast embedded below:
Dr. Charles Brenner (FAQs), University of Iowa professor, chief scientific advisor at Chromadex, and discoverer of Nicotinamide Riboside “NR” (FAQs) (Reviews) as an NAD precursor vitamin joined the Ben Greenfield Fitness Podcast to discuss NAD+, NR, and lots more. Key quotes and podcast embedded: